Miguel Xavier
Fernandes
Ikertzailea 2013-2022 tartean
University of Turin
Turín, ItaliaUniversity of Turin-ko ikertzaileekin lankidetzan egindako argitalpenak (1)
2022
-
A Comprehensive Evaluation of Sdox, a Promising H2S-Releasing Doxorubicin for the Treatment of Chemoresistant Tumors
Frontiers in Pharmacology, Vol. 13